fda compounding semaglutide crackdown news november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Warns on Certain Forms
Description
In patients with type 2 diabetes mellitus (T2DM), insulin secretion is markedly decreased or absent [2], and GLP-1 receptor agonists (GLP-1 RA) have been shown to improve glycemic control in this population [3, 4]
The glucagon receptor activation is the key differentiator
While some insurance plans may cover semaglutide prescriptions, Vive Aesthetics & Wellness does not accept insurance for office visits or treatments
It is a tolerance-building phase
For men, t
But over time, that progress can slow or stop all together
